Matt Windsor

Matt Windsor

| This email address is being protected from spambots. You need JavaScript enabled to view it.

With funding from UAB’s urgent COVID-19 research grants, researchers are testing penehyclidine to halt the acute respiratory distress syndrome seen in seriously ill patients by defending crucial cell barriers.

Clinical trials of monoclonal antibodies and convalescent plasma offer new options to outpatients in the first days after a COVID-19 diagnosis.

President Watts and other senior leaders responded to queries on the hiring freeze, student mental health, working from home in 2021 and more.

A novel detergent-like compound developed by UAB researchers that blocks HIV and HSV viruses from entering cells could have the same effect against the virus that causes COVID-19. The team is exploring the compound’s potential with a commercialization grant from the U.S. Economic Development Administration.

Benjamin Larimer, Ph.D., has received a five-year, $1.5-million New Innovator Award grant to develop a PET imaging test that identifies patients most likely to benefit from immunotherapy.

Using extensive testing, diagnosis and clinical data from across the Deep South, this project will be the first to analyze multiple dimensions of inequality to clarify contributions to COVID-19 disparities.

ScopeAssist, invented by a physician and an engineer, is designed to help surgeons deal with the rigors associated with endoscopic surgeries.

The 2020 Disability Employment Summit – Diversity through Inclusion, sponsored by the Alabama Department of Rehabilitation Services, includes speakers from Alabama and beyond. Register today.

Easy tips and tricks from UAB experts on how to look your best, professionally and personally, during video meetings.

COVID-19 has changed the centuries-old process of defending dissertations and theses. Graduate School Dean Lori McMahon, Ph.D., and Associate Dean David Schneider, Ph.D., explain which changes are temporary and which could become permanent.

Page 29 of 49